Neogen Chemicals Limited — Credit Ratings, 18-03-2025: Credit Rating

Neogen Chemicals has announced a board meeting on the financial results for the quarter and half-year. Consolidated revenue reached ₹320 crore, reflecting a notable year-over-year growth of 15%. This increase is driven by rising demand in the specialty chemicals sector and successful market expansion initiatives.

Net profit for the quarter stood at ₹45 crore, up from ₹35 crore, translating to Earnings Per Share (EPS) of ₹4.50, driven by improved operational efficiencies and cost management, despite increases in raw material prices. Operational costs were up by 10%, largely attributed to higher input costs and expansion-related expenses, prompting the company to enhance its cost control measures.

The balance sheet shows a healthy position with total assets of ₹1,200 crore and liabilities of ₹600 crore, providing a solid capital structure. Cash flow remains robust, supporting ongoing investments in innovation and expansion.

Strategically, the focus will remain on enhancing production capabilities and tapping into new markets, reflecting positive sentiment in the investor community. Given the positive financial performance and solid market positioning, the insight leans towards a buy stance, presenting favorable long-term growth potential amidst manageable cost pressures.

In credit rating updates, CRISIL has placed the long-term ratings of Neogen Chemicals on ‘Watch with Developing Implications’, reflecting the company’s stable financial health but cautioning on future developments. This could influence borrowing costs, highlighting the need for continued vigilance in financial management.